-
ERIC GALIN
Barcelona

The blood products company accuses the drop in plasma donations since the pandemic, and the consequent impact on its margins, and announces a plan to save 400 million in costs.
grifols He has pulled out the scissors after the problems suffered by his business since the outbreak of the pandemic and the pressure from investors to reduce the debt, triggered after the purchase of the German company Biotest. The company of blood products ad ay
To continue reading become Premium
Try it for €1 the first month
and enjoy unlimited access to all Expansión web content
Or sign up with your Google account in two clicks
- Catalonia
- Companies